- Nexalin Technology (NXL, Financial) has launched phases one through five of its virtual clinic and digital ecosystem.
- The AI-powered platform supports the TBI/PTSD military study at UCSD using the HALO™ headset.
- Key features include AI-powered data capture, remote monitoring, and telemedicine integration.
Nexalin Technology, Inc. (NXL) has successfully completed the first five phases of its proprietary virtual clinic and digital research ecosystem, a significant milestone for the company in advancing its AI-powered healthcare solutions. The system was launched at the University of California, San Diego (UCSD) to facilitate a newly announced study targeting traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD) in military personnel using the HALO™ headset.
This comprehensive digital infrastructure enables both civilian and military patients to undergo Deep Intracranial Frequency Stimulation (DIFS™) treatments at home, while maintaining compliance with clinical protocols. The AI-integrated platform features:
AI-powered Electronic Data Capture (EDC) for secure and real-time clinical data collection and analysis.
A Remote Patient Monitoring System (PMS), which allows clinicians to supervise treatment sessions and provide real-time feedback through mobile apps.
Telemedicine integration to support virtual treatments and enhance patient interaction with healthcare providers.
Cloud-based compliance management to ensure regulatory adherence and secure data storage for clinical trials.
Mark White, CEO of Nexalin Technology, emphasized the importance of this development, stating that the fully integrated AI-powered system will significantly enhance their clinical research capabilities and patient care protocols. With this infrastructure, Nexalin is poised to facilitate ongoing studies, improve accessibility to treatments, especially for patients with mobility issues, and expedite the commercialization of HALO™ and future DIFS™ technology applications.
As the HALO™ headset continues to undergo clinical evaluations, this digital ecosystem offers a foundational platform that supports research in mental health disorders, TBI, addiction, and neurodegenerative conditions. It also strengthens Nexalin's position in the healthcare technology sector by ensuring treatment protocol adherence and optimizing patient outcomes through advanced treatment monitoring and data management solutions.
